FDA Device Intelligence
Home › Shire Human Genetic Therapies, Inc. › Anti-Drug Antibody Biomarker Specimen Collection Kit: Gaucher and Hunter Patient

Anti-Drug Antibody Biomarker Specimen Collection Kit: Gaucher and Hunter Patient

Shire Human Genetic Therapies, Inc. · Model 1 · UDI-DI 05060147022339

PQD Prescription
0
510(k) clearances
19
Adverse events
1
Recalls
53
Facilities

Description

The purpose of the Anti-Drug Antibody and Biomarker Specimen Collection Kit is to aid healthcare providers (HCPs) in collecting specimens from patients receiving ELAPRASE® or VPRIV® commercial therapy for the treatment of Hunter syndrome and Gaucher.

Recalls

DateFirmReason
2022-03-16LetsGetChecked Inc.Users received sample collection kits that were assigned to another user. Incorrect shipping labels were applied to the collection kits. As a result, a number of users received sa

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.